HYDROXYUREA Side Effects

5097881-8 | Pseudomonas Infection, Skin Ulcer
on Sep 05, 2006 Male patient from UNITED STATES , 74 years of age, weighting 193.0 lb, was diagnosed with polycythaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: pseudomonas infection, skin ulcer. Hydroxyurea dosage: 500 Mg Bid.

5096958-0 | Chest Pain, Contusion, Ear Disorder, Ear Haemorrhage, Epistaxis, Nasal Disorder, Night Sweats, Pneumonia, Sinus Headache
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: chest pain (What is chest pain?), contusion, ear disorder, ear haemorrhage, epistaxis, nasal disorder, night sweats, pneumonia (What is pneumonia?), sinus headache on Aug 31, 2006 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 156.0 lb, was diagnosed with chronic myeloid leukaemia and. Hydroxyurea dosage: 500 Mg. During the same period patient was treated with VERDENAFIL HCL (View Verdenafil Hcl Review and Verdenafil Hcl Label ), HYDROXYZINE PAMOATE (View Hydroxyzine Pamoate Review and Hydroxyzine Pamoate Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

5071560-5 | Blood Creatinine Increased, Blood Phosphorus Increased, Blood Potassium Increased, Blood Urea Increased, Metabolic Acidosis, Sepsis, Tumour Lysis Syndrome
Adverse event was reported on Aug 03, 2006 by a Male patient taking Hydroxyurea (View Usage) (Dosage: 1000 Mg Tid With Food) was diagnosed with leukaemia and. Location: UNITED STATES , 57 years of age, weighting 133.6 lb, After Hydroxyurea was administered, patient had the following side effects: blood creatinine increased, blood phosphorus increased, blood potassium increased, blood urea increased, metabolic acidosis, sepsis (What is sepsis?), tumour lysis syndrome. Patient was hospitalized.

5067399-7 | Abscess, Embolism, Leukocytosis, Platelet Count Decreased, Postoperative Wound Complication, Skin Ulcer, Thrombocythaemia
on Jul 12, 2006 Female patient from JAPAN , 75 years of age, was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), embolism, leukocytosis, platelet count decreased, postoperative wound complication, skin ulcer, thrombocythaemia. Hydroxyurea dosage: 500 Mg Qday Po. Patient was hospitalized.


5028996-8 | Abortion Spontaneous
on Jun 07, 2006 Female patient from CHILE , 20 years of age, weighting 114.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: abortion spontaneous. Hydroxyurea dosage: . During the same period patient was treated with GLEEVEC (Unk, Unk) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5007619-8 | Sickle Cell Anaemia With Crisis
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: sickle cell anaemia with crisis on May 12, 2006 from UNITED STATES Additional patient health information: Male patient , 26 years of age, was diagnosed with blood iron increased and. Hydroxyurea dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), EXJADE (1500 Mg, Qd) (View Exjade Review and Exjade Label ). Patient was hospitalized.

4992243-3 | Bone Marrow Failure, Petechiae
Adverse event was reported on Apr 19, 2006 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 4000 Mg Qday Po) was diagnosed with thrombocythaemia and. Location: UNITED STATES , 80 years of age, weighting 176.0 lb, Patient experienced the following unwanted or unexpected effects: bone marrow failure, petechiae. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4986969-5 | Candidiasis, Escherichia Bacteraemia
on Dec 19, 2005 Female patient from UNITED STATES , 39 years of age, weighting 112.4 lb, was treated with Hydroxyurea (View Usage). Patient had the following side effects: candidiasis, escherichia bacteraemia. Hydroxyurea dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

4962306-7 | Platelet Count Increased
on Feb 21, 2006 Female patient from UNITED STATES , 92 years of age, was diagnosed with polycythaemia vera, peripheral vascular disorder and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: platelet count increased. Hydroxyurea dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ).

4962303-1 | Eustachian Tube Disorder, Hypoacusis, Mucosal Inflammation, Rash
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: eustachian tube disorder, hypoacusis, mucosal inflammation, rash (What is rash?) on Dec 29, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 130.1 lb, was diagnosed with platelet count increased and. Hydroxyurea dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), NEXIUM (View Nexium Review and Nexium Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PAXIL (View Paxil Review and Paxil Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ).

4962290-6 | Headache, Visual Disturbance
Adverse event was reported on Jul 19, 2005 by a Female patient taking Hydroxyurea (View Usage) (Dosage: ) was diagnosed with thrombocythaemia and. Location: UNITED STATES , weighting 149.9 lb, Patient had the following side effects: headache (What is headache?), visual disturbance. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4962286-4 | Hypersensitivity, Rash
on May 13, 2005 Female patient from UNITED STATES , 32 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: hypersensitivity, rash (What is rash?). Hydroxyurea dosage: .

4941168-8 | Bacteria Stool Identified, Clostridial Infection, Hypoxia, Pyrexia, Respiratory Distress
on Mar 10, 2006 Male patient from UNITED STATES , 59 years of age, weighting 137.0 lb, was diagnosed with neoplasm malignant and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: bacteria stool identified, clostridial infection, hypoxia, pyrexia, respiratory distress. Hydroxyurea dosage: 500 Mg Po Qhs. During the same period patient was treated with FLUOROURACIL (1056 Mg Ci Iv X5 Q2w) (View Fluorouracil Review and Fluorouracil Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CODEINE PHOSPHATE AND ACETAMINOPHEN (View Codeine Phosphate And Acetaminophen Review and Codeine Phosphate And Acetaminophen Label ), CHOCHICINE (View Chochicine Review and Chochicine Label ), DUCOSATE NA (View Ducosate Na Review and Ducosate Na Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

4927954-9 | Sarcoidosis
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: sarcoidosis on Jan 18, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 70 years of age, was diagnosed with essential thrombocythaemia and. Hydroxyurea dosage: .

4911167-0 | Hypospadias, Urethral Repair
Adverse event was reported on Feb 01, 2006 by a Male patient taking Hydroxyurea (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 6.13 lb, After Hydroxyurea was administered, patient had the following side effects: hypospadias, urethral repair. During the same period patient was treated with ANAGRELIDE (View Anagrelide Review and Anagrelide Label ), IMATINIB (View Imatinib Review and Imatinib Label ). Patient was hospitalized.

4910875-5 | Hypospadias, Urethral Repair
on Feb 01, 2006 Male patient from UNITED STATES , weighting 6.13 lb, was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: hypospadias, urethral repair. Hydroxyurea dosage: . During the same period patient was treated with ANAGRELIDE (View Anagrelide Review and Anagrelide Label ), IMATINIB (View Imatinib Review and Imatinib Label ). Patient was hospitalized.

4894385-X | Sarcoidosis
on Jan 18, 2006 Male patient from UNITED KINGDOM , 70 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: sarcoidosis. Hydroxyurea dosage: .

4868190-4 | Bacteraemia, Dehydration, Pyrexia
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: bacteraemia, dehydration, pyrexia on Dec 19, 2005 from UNITED STATES Additional patient health information: Female patient , 39 years of age, weighting 112.4 lb, . Hydroxyurea dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

4862620-X | Dyspnoea, Nail Pigmentation, Palpitations, Skin Atrophy, Skin Hyperpigmentation, Squamous Cell Carcinoma, Treatment Related Secondary Malignancy, Ventricular Fibrillation
Adverse event was reported on Dec 08, 2005 by a Male patient taking Hydroxyurea (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: TURKEY , 73 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, nail pigmentation, palpitations, skin atrophy, skin hyperpigmentation, squamous cell carcinoma, treatment related secondary malignancy, ventricular fibrillation. Patient was hospitalized.

4822065-5 | Actinic Keratosis, Bowen's Disease, Metastases To Liver, Metastases To Lymph Nodes, Neuroendocrine Carcinoma Of The Skin, Skin Disorder
on Oct 19, 2005 Female patient from , 59 years of age, was diagnosed with thrombocytopenia, neuroendocrine carcinoma and was treated with Hydroxyurea (View Usage). Patient had the following side effects: actinic keratosis, bowen's disease, metastases to liver, metastases to lymph nodes, neuroendocrine carcinoma of the skin, skin disorder. Hydroxyurea dosage: . During the same period patient was treated with BUSULFAN (BUSULFAN) (View Busulfan (busulfan) Review and Busulfan (busulfan) Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

4789683-4 | Colitis
on Sep 25, 2005 Male patient from JAPAN , 62 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: colitis. Hydroxyurea dosage: .

4788848-5 | Cerebral Haemorrhage, Disease Progression, Erythema, Mouth Ulceration, Oedema Peripheral, Platelet Count Decreased, Skin Hyperpigmentation, Skin Toxicity, Stomatitis
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, disease progression, erythema, mouth ulceration, oedema peripheral, platelet count decreased, skin hyperpigmentation, skin toxicity, stomatitis on Sep 27, 2005 from DENMARK Additional patient health information: Male patient , 33 years of age, was diagnosed with acute myeloid leukaemia and. Hydroxyurea dosage: . During the same period patient was treated with MITOZANTRONE (View Mitozantrone Review and Mitozantrone Label ).

4786659-8 | Glioblastoma Multiforme, Malignant Neoplasm Progression
Adverse event was reported on Oct 03, 2005 by a Male patient taking Hydroxyurea (View Usage) (Dosage: 500mg Po Bid) was diagnosed with glioblastoma multiforme and. Location: UNITED STATES , weighting 186.7 lb, Patient had the following side effects: glioblastoma multiforme, malignant neoplasm progression. During the same period patient was treated with PTK787 (500mg Po Qd) (View Ptk787 Review and Ptk787 Label ), GLEEVEC (600mg Po Qd) (View Gleevec Review and Gleevec Label ), DILANTIN (View Dilantin Review and Dilantin Label ), DECADRON (View Decadron Review and Decadron Label ), PROTONIX (View Protonix Review and Protonix Label ).

4786045-0 | Asthenia, Convulsion, Oral Candidiasis
on Sep 30, 2005 Female patient from UNITED STATES , weighting 153.7 lb, was diagnosed with glioblastoma multiforme and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: asthenia, convulsion, oral candidiasis. Hydroxyurea dosage: 500mg Po Bid. During the same period patient was treated with GLEEVEC (400mg Po Qd) (View Gleevec Review and Gleevec Label ), PREMARIN (View Premarin Review and Premarin Label ), NEXIUM (View Nexium Review and Nexium Label ), DECADRON (View Decadron Review and Decadron Label ), DETROL LA (View Detrol La Review and Detrol La Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

4767858-8 | Thrombosis, Ulcer
on Aug 25, 2005 Male patient from UNITED STATES , 74 years of age, was diagnosed with polycythaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis, ulcer (What is ulcer?). Hydroxyurea dosage: 500 Mg Qday Po. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), COZAAR (View Cozaar Review and Cozaar Label ), LASIX (View Lasix Review and Lasix Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ).

4749905-2 | Acute Myocardial Infarction, Blood Viscosity Increased, Foetal Haemoglobin Increased, Haematocrit Increased, Haemoglobin Abnormal, Mean Cell Volume Increased, Ventricular Dysfunction
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: acute myocardial infarction, blood viscosity increased, foetal haemoglobin increased, haematocrit increased, haemoglobin abnormal, mean cell volume increased, ventricular dysfunction on Aug 04, 2005 from BRAZIL Additional patient health information: Male patient , 28 years of age, was diagnosed with sickle cell anaemia and. Hydroxyurea dosage: . Patient was hospitalized.

4748207-8 | International Normalised Ratio Increased, Joint Swelling
Adverse event was reported on Aug 12, 2005 by a Female patient taking Hydroxyurea (View Usage) (Dosage: ) was diagnosed with myeloproliferative disorder, pulmonary embolism (What is pulmonary embolism?), dizziness (What is dizziness?), atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED KINGDOM , 81 years of age, After Hydroxyurea was administered, patient had the following side effects: international normalised ratio increased, joint swelling. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), BETAHISTINE DIHYDROCHLORIDE (View Betahistine Dihydrochloride Review and Betahistine Dihydrochloride Label ). Patient was hospitalized.

4737994-0 | Mental Status Changes, Neuropathic Pain, Pancytopenia, Sedation
on Aug 05, 2005 Male patient from UNITED STATES , 79 years of age, weighting 136.7 lb, was diagnosed with essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: mental status changes, neuropathic pain, pancytopenia, sedation. Hydroxyurea dosage: 500 Mg Po Bid.

4725579-1 | Anaplastic Astrocytoma, Neutropenia
on Jul 22, 2005 Female patient from UNITED STATES , weighting 129.6 lb, was treated with Hydroxyurea (View Usage). Patient had the following side effects: anaplastic astrocytoma, neutropenia. Hydroxyurea dosage: 500 Mg Po Qd. During the same period patient was treated with GLEEVEC (400 Mg Po Bid) (View Gleevec Review and Gleevec Label ), DILANTIN (View Dilantin Review and Dilantin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), RESTORIL (View Restoril Review and Restoril Label ), VALIUM (View Valium Review and Valium Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

4725117-3 | Ageusia, Anosmia
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: ageusia, anosmia on Jul 15, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 185.0 lb, was diagnosed with platelet count increased, polycythaemia vera and. Hydroxyurea dosage: See Image, Oral. During the same period patient was treated with DIPYRIDAMOLE (View Dipyridamole Review and Dipyridamole Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), COMPAZINE (View Compazine Review and Compazine Label ).

4680770-8 | Neutropenia
Adverse event was reported on May 31, 2005 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 500 Mg Po Bid) was diagnosed with anaplastic astrocytoma and. Location: , weighting 125.2 lb, Patient experienced the following unwanted or unexpected effects: neutropenia. During the same period patient was treated with GLEEVEC (600 Mg Po Bid) (View Gleevec Review and Gleevec Label ), DILANTIN (View Dilantin Review and Dilantin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), RESTORIL (View Restoril Review and Restoril Label ), VALIUM (View Valium Review and Valium Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

4679254-2 | Neutropenia, Neutrophil Count Decreased
on May 31, 2005 Female patient from , weighting 125.2 lb, was diagnosed with anaplastic astrocytoma and was treated with Hydroxyurea (View Usage). Patient had the following side effects: neutropenia, neutrophil count decreased. Hydroxyurea dosage: 500 Mg Po Bid. During the same period patient was treated with GLEEVEC (600 Mg Po Bid) (View Gleevec Review and Gleevec Label ), DILANTIN (View Dilantin Review and Dilantin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), RESTORIL (View Restoril Review and Restoril Label ), VALIUM (View Valium Review and Valium Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

4664792-9 | Anaemia, Thrombocytopenia
on May 17, 2005 Male patient from , 60 years of age, was diagnosed with myeloproliferative disorder and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: anaemia, thrombocytopenia. Hydroxyurea dosage: 2500mg Daily Po. Patient was hospitalized.

4664149-0 | Haematocrit Decreased, Pancytopenia, White Blood Cell Count Abnormal
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: haematocrit decreased, pancytopenia, white blood cell count abnormal on May 16, 2005 from Additional patient health information: Male patient , 58 years of age, was diagnosed with essential thrombocythaemia, alcoholism (What is alcoholism?), dysthymic disorder, major depression, post-traumatic stress disorder (What is post-traumatic stress disorder?) and. Hydroxyurea dosage: 500mg Po Tid. During the same period patient was treated with TOPIRAMATE (50mg Po Bid) (View Topiramate Review and Topiramate Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ). Patient was hospitalized.

4654526-6 | Abdominal Pain Upper, Ascites, Cardiac Tamponade, Cough, Deep Vein Thrombosis, Hepatitis, Pericardial Effusion, Pleural Effusion
Adverse event was reported on May 03, 2005 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 500mg Po Bid) was diagnosed with glioblastoma multiforme and. Location: , weighting 205.5 lb, Patient had the following side effects: abdominal pain upper, ascites, cardiac tamponade, cough, deep vein thrombosis (What is deep vein thrombosis?), hepatitis (What is hepatitis?), pericardial effusion, pleural effusion. During the same period patient was treated with GLEEVEC (600mg Po Bid) (View Gleevec Review and Gleevec Label ), DILANTIN (View Dilantin Review and Dilantin Label ), ZOFRAN (View Zofran Review and Zofran Label ), PREVACID (View Prevacid Review and Prevacid Label ), DARVOCET (View Darvocet Review and Darvocet Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

4637410-3 | Blood Cholesterol Increased, Blood Triglycerides Increased
on Nov 01, 2004 Female patient from , 74 years of age, weighting 154.3 lb, was diagnosed with platelet count increased and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased. Hydroxyurea dosage: Decreased To 200mg - 1 Daily (present). During the same period patient was treated with ELAVIL (View Elavil Review and Elavil Label ), CELEBREX (1-2 200 Mg Tablets Daily) (View Celebrex Review and Celebrex Label ).

4637409-7 | Pregnancy
on Oct 20, 2004 Female patient from , 25 years of age, was diagnosed with sickle cell anaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?). Hydroxyurea dosage: .

4637406-1 | Chills, Dysgeusia, Pyrexia, Skin Lesion, Tongue Coated
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: chills, dysgeusia, pyrexia, skin lesion, tongue coated on Aug 27, 2004 from Additional patient health information: Male patient , 49 years of age, weighting 194.0 lb, was diagnosed with polycythaemia vera and. Hydroxyurea dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

4619854-9 | Respiratory Distress
Adverse event was reported on Mar 21, 2005 by a Female patient taking Hydroxyurea (View Usage) (Dosage: 6000 Mg Po X 1; 1500 Mg Po X 1) was diagnosed with thrombocythaemia and. Location: , 80 years of age, weighting 127.9 lb, After Hydroxyurea was administered, patient had the following side effects: respiratory distress. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), TRIAMTERENE AND HYDROCHLOROTHIAZIDE (View Triamterene And Hydrochlorothiazide Review and Triamterene And Hydrochlorothiazide Label ), NITROTABS (View Nitrotabs Review and Nitrotabs Label ). Patient was hospitalized.

4590859-X | Deep Vein Thrombosis
on Feb 22, 2005 Male patient from , weighting 236.3 lb, was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?). Hydroxyurea dosage: 500mg Po Bid. During the same period patient was treated with GLEEVEC (500 Mg Po Bid) (View Gleevec Review and Gleevec Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PROTONIX (View Protonix Review and Protonix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ALTRACE (View Altrace Review and Altrace Label ), XANAX (View Xanax Review and Xanax Label ).

4585780-7 | Anaemia, Asthenia, Dyspnoea
on Jan 28, 2005 Male patient from , 83 years of age, weighting 184.1 lb, was diagnosed with thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: anaemia, asthenia, dyspnoea. Hydroxyurea dosage: 500 Mg Daily. During the same period patient was treated with NOVOLIN 70/30 (View Novolin 70/30 Review and Novolin 70/30 Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), LASIX (View Lasix Review and Lasix Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), BRIMONIDINE (View Brimonidine Review and Brimonidine Label ). Patient was hospitalized.

4585387-1 | Deep Vein Thrombosis, Skin Ulcer
Patient was taking Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), skin ulcer on Feb 08, 2005 from Additional patient health information: Male patient , 84 years of age, was diagnosed with polycythaemia vera and. Hydroxyurea dosage: .

4585384-6 | Skin Necrosis, Vasculitis
Adverse event was reported on Feb 08, 2005 by a Male patient taking Hydroxyurea (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: , 55 years of age, Patient experienced the following unwanted or unexpected effects: skin necrosis, vasculitis (What is vasculitis?).

4585383-4 | Peripheral Occlusive Disease, Skin Ulcer
on Feb 08, 2005 Female patient from , 81 years of age, was diagnosed with essential thrombocythaemia and was treated with Hydroxyurea (View Usage). Patient had the following side effects: peripheral occlusive disease, skin ulcer. Hydroxyurea dosage: Dose Increased To 1.5 G/day. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

4584377-2 | Gangrene
on Feb 10, 2005 Female patient from , 55 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: gangrene. Hydroxyurea dosage: . During the same period patient was treated with INTERFERON (Dose: 5 Mu Daily) (View Interferon Review and Interferon Label ).

4584370-X | Gangrene, Skin Ulcer
Patient was taking Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: gangrene, skin ulcer on Feb 10, 2005 from Additional patient health information: Male patient , 35 years of age, was diagnosed with chronic myeloid leukaemia and. Hydroxyurea dosage: . During the same period patient was treated with INTERFERON (Dose: 8 Mu Daily) (View Interferon Review and Interferon Label ).

4584368-1 | Skin Necrosis
Adverse event was reported on Feb 10, 2005 by a Male patient taking Hydroxyurea (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia and. Location: , 67 years of age, Patient had the following side effects: skin necrosis. During the same period patient was treated with INTERFERON (Dose = 10 Mu Daily) (View Interferon Review and Interferon Label ).

4584363-2 | Gangrene, Skin Ulcer
on Feb 10, 2005 Male patient from , 46 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). After Hydroxyurea was administered, patient had the following side effects: gangrene, skin ulcer. Hydroxyurea dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).

4584361-9 | Gangrene
on Feb 10, 2005 Male patient from , 60 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Hydroxyurea (View Usage). Patient experienced the following unwanted or unexpected effects: gangrene. Hydroxyurea dosage: . During the same period patient was treated with INTERFERON (Dose: 7 Mu Daily) (View Interferon Review and Interferon Label ).

4584360-7 | Gangrene, Skin Ulcer
Patient was taking Hydroxyurea (View Usage). Patient had the following side effects: gangrene, skin ulcer on Feb 10, 2005 from Additional patient health information: Male patient , 60 years of age, was diagnosed with chronic myeloid leukaemia and. Hydroxyurea dosage: . During the same period patient was treated with INTERFERON (View Interferon Review and Interferon Label ).